Apremilast is an orally administered small-molecule compound that functions as a selective inhibitor of phosphodiesterase 4 (PDE4). It is used as an active pharmaceutical ingredient in the manufacturing of medications for certain inflammatory conditions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Apremilast?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
O-demethyl apremilast
pharmaceutical intermediate
O3-Desethyl Apremilast
pharmaceutical intermediate
Acetaminophen-d3
pharmaceutical raw material
Tasimelteon
pharmaceutical raw material
4-Hydroxymethyl Loratadine
pharmaceutical raw material
Dibucaine hydrochloride
pharmaceutical raw material
Acetamide, N-[2-[(1S)-1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-
pharmaceutical intermediate
The international HS code for Apremilast (CAS 608141-41-9) is 2930.90.
2930.90
2930 90 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide
IMOZEMNVLZVGJZ-QGZVFWFLSA-N
CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC
Sourcing Apremilast?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.